PD-1 and CTLA-4 expression is known to be elevated in viral antigen-specific T cells in patients with chronic HCV infection [151], and ICIs are thought to be promising not only for HCV treatment but also for HCC treatment. Here, CTLA4 is linked to hepatocellular carcinoma.